Message from Chairman
"Telix is now a global radiopharmaceutical company with a specialist commercial organization, a deep pipeline of late-stage and next-generation theranostic programs, and global manufacturing capabilities. We are further differentiated by our end-to-end solutions for patients and our fully integrated radiopharma ecosystem."
Read more
Message from CEO
“Having built a strong foundation over the last few years, and with several major inflection points achieved in 2024, we are on the cusp of exponential growth. I believe that Telix can be the global leader of this rapidly growing field of medicine, setting the standard and charting the course ahead for radiopharmaceuticals to change the way we ‘see and treat’ cancer.”
Read more
